Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 8 matching records.
8 results — page 1 of 1
- Level DAnimal StudyPubMed
Allogeneic gene therapy with BMP-2-transduced mesenchymal stem cells combined with immunosuppression enhances bone healing.
Animal Study on Immune Modulation, published in Mol Ther (2025) — summary generated from the PubMed abstract.
- 2025
Mol Ther - Level DAnimal StudyPubMed
Immunosuppression-enhancing effect of the administration of allogeneic canine adipose-derived mesenchymal stem cells (cA-MSCs) compared with autologous cA-MSCs in vitro .
Animal Study on Face & Skin, published in J Vet Sci (2021) — summary generated from the PubMed abstract.
- 2021
J Vet Sci7 citations - Level DAnimal StudyPubMed
Multiple doses of adipose tissue-derived mesenchymal stromal cells induce immunosuppression in experimental asthma.
Animal Study on Systemic / IV, published in Stem Cells Transl Med (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cells Transl Med41 citations - Level DAnimal StudyPubMed
Culture and properties of adipose-derived mesenchymal stem cells: characteristics in vitro and immunosuppression in vivo.
Animal Study on Systemic / IV, published in Int J Clin Exp Pathol (2015) — summary generated from the PubMed abstract.
- 2015
Int J Clin Exp Pathol14 citations - Level CProspective StudyPubMed
Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.
Prospective Study with a reported sample of 95 on Systemic / IV, published in Ren Fail (2014) — summary generated from the PubMed abstract.
- 2014
- n = 95
Ren Fail22 citations - Level BClinical TrialPubMed
Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
Clinical Trial on Systemic / IV, published in Cell Transplant (2012) — summary generated from the PubMed abstract.
- 2012
Cell Transplant36 citations - Level DAnimal StudyPubMed
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.
Animal Study on Immune Modulation, Autoimmune Research, published in Stem Cell Res Ther (2010) — summary generated from the PubMed abstract.
- 2010
Stem Cell Res Ther - Level DNarrative ReviewPubMed
[Mesenchymal stem cells and the immune system--immunosuppression without drugs?].
Narrative Review on Tendon Injury, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Orv Hetil (2008) — summary generated from the PubMed abstract.
- 2008
Orv Hetil
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406